AGC-16967-06745
2 vaccinations
9 coded responses
13 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 254 / WV
- Registered
- 2021-04-10
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Dose 1 — Pfizer-BioNTech
-
2021-04-08
Dose 2 — Pfizer-BioNTech
-
2021-04-10
Registered in v-safe
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Paralysis — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Alternating paralysis and poor muscle control/coordination.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Muscle disorder, Muscle spasticity, Muscular weakness, Paralysis — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: Muscle control issues. Muscle weakness. Spasticity. ParalysisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Survey response — days 1–6 daily, dose 2MedDRA: Coordination abnormal, Muscle disorder, Visual impairment — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Muscle control and coordination problems . Vision problems.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-13
Survey response — days 1–6 daily, dose 2MedDRA: Muscular weakness — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Muscle weakness/lack of controlMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-15
Survey response — day 7, dose 2MedDRA: Muscular weakness — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Muscle weakness and poor controlMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Survey response — day 14, dose 2MedDRA: Arterial disorder, Office visit — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Extreme arterial swelling. BP 60/30. Had to visit doctor and be prescribed vasoconstrictors and anti inflammatories.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-29
Survey response — day 21, dose 2MedDRA: Arteritis, Oral mucosal eruption — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Mouth rash and arterial swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-29
Report sent to call center — day 21, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-06
Survey response — day 28, dose 2MedDRA: Superficial vein thrombosis — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Superficial thrombosisMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
- 2021-05-20
-
2021-07-08
Survey response — 3 months, dose 2MedDRA: Heart rate increased — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Elevated heart rateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-10-09
- 2022-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Pfizer-BioNTech | |
| 2 | 2021-04-08 | Pfizer-BioNTech |
Call center
3 call center cases
3 unsuccessful
1 wait over 3 months for a first call
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Alternating paralysis and poor muscle control/coordination.
Systemic reaction (other): Muscle control issues. Muscle weakness. Spasticity. Paralysis
Systemic reaction (other): Muscle control and coordination problems . Vision problems.
Systemic reaction (other): Muscle weakness/lack of control
Release 7 — day 7, dose 2
Systemic reaction (other): Muscle weakness and poor control
Release 7 — day 14, dose 2
Symptoms: Extreme arterial swelling. BP 60/30. Had to visit doctor and be prescribed vasoconstrictors and anti inflammatories.
Release 8 — day 21, dose 2
Symptoms: Mouth rash and arterial swelling
Release 8 — day 28, dose 2
Symptoms: Superficial thrombosis
Release 9 — 3 months, dose 2
Symptoms: Elevated heart rate
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arterial disorder | ✓ | ✓ | ✓ |
| SD | Arteritis | ✓ | ✓ | ✓ |
| SD | Heart rate increased | ✓ | ✓ | ✓ |
| SD | Office visit | ✓ | ✓ | ✓ |
| SD | Oral mucosal eruption | ✓ | ✓ | ✓ |
| SD | Superficial vein thrombosis | ✓ | ✓ | ✓ |
| SRO | Coordination abnormal | ✓ | ✓ | ✓ |
| SRO | Muscle disorder | ✓ | ✓ | ✓ |
| SRO | Muscle spasticity | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Paralysis | ✓ | ✓ | ✓ |
| SRO | Visual impairment | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release